About Bio-Techne Corp. 
Bio-Techne Corp.
Pharmaceuticals & Biotechnology
Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.
Company Coordinates 
Company Details
614 McKinley Pl NE , MINNEAPOLIS MN : 55413-2610
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 135 Schemes (52.11%)
Foreign Institutions
Held by 290 Foreign Institutions (18.37%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Robert Baumgartner
Independent Chairman of the Board
Mr. Charles Kummeth
President, Chief Executive Officer, Director
Ms. Julie Bushman
Independent Director
Mr. John Higgins
Independent Director
Dr. Joseph Keegan
Independent Director
Dr. Roeland Nusse
Independent Director
Dr. Alpna Seth
Independent Director
Revenue and Profits:
Net Sales:
317 Million
(Quarterly Results - Jun 2025)
Net Profit:
-18 Million
Pharmaceuticals & Biotechnology
USD 8,417 Million (Small Cap)
37.00
NA
44.91%
0.10
11.21%
4.39






